Related references
Note: Only part of the references are listed.Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review
Elizabeth Gargon et al.
PLOS ONE (2014)
Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: A retrospective two-center cohort study
Patrizia Binz et al.
PEDIATRIC BLOOD & CANCER (2013)
The reporting of outcomes in studies of fever and neutropenia in children with cancer: Time for consensus
Gabrielle M. Haeusler et al.
PEDIATRIC BLOOD & CANCER (2013)
Antibiotic-resistant Gram-negative Bacteremia in Pediatric Oncology Patients-Risk Factors and Outcomes
Gabrielle M. Haeusler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
An Updated Systematic Review and Meta-analysis of the Predictive Value of Serum Biomarkers in the Assessment of Fever During Neutropenia in Children With Cancer
Gabrielle M. Haeusler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care
F. Gibson et al.
SUPPORTIVE CARE IN CANCER (2013)
Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
Jamie J. Kirkham et al.
TRIALS (2013)
Can a core outcome set improve the quality of systematic reviews? - a survey of the Co-ordinating Editors of Cochrane review groups
Jamie J. Kirkham et al.
TRIALS (2013)
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
Robert S. Phillips et al.
BMC MEDICINE (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Rationalizing the approach to children with fever in neutropenia
Roland A. Ammann et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
Thomas Lehrnbecher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia
Robert S. Phillips et al.
PLOS ONE (2012)
Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: Results of the prospective multicenter SPOG 2003 FN study
Fabienne Luethi et al.
PEDIATRIC BLOOD & CANCER (2012)
Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review
Laura Rodriguez et al.
SUPPORTIVE CARE IN CANCER (2012)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies
Ian P. Sinha et al.
PLOS MEDICINE (2011)
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
Bob Phillips et al.
EUROPEAN JOURNAL OF CANCER (2010)
Predicting Adverse Events in Children With Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter SPOG 2003 FN Study
Roland A. Ammann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Risk Prediction in Pediatric Cancer Patients With Fever and Neutropenia
Hana Hakim et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children
Ian Sinha et al.
PLOS MEDICINE (2008)
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
Bob Phillips et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2007)
A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia
Patricia Imperatriz Porto Rondinelli et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab
KA Thursky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: Updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies
R Feld et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
